September 8, 2024 — What’s the harm? For many “interventions” to reduce obesity prevalence, this rationale seems to be good enough to spur implementation. Menu labeling is a good example. Restaurants in the U.S. and in numerous other places must publish the number of calories in food portions they sell. This went into effect based upon suppositions. Policy makers […]
August 7, 2024 — The U.S. military has a problem with obesity and frankly has no clue of how to deal with it. The prevalence of obesity in the population has grown so that the services cannot run from the problem. Simply expelling service members because of their size no longer works to maintain military readiness. The supply of […]
August 4, 2024 — Warning: this is a bit of a rant, albeit a good-natured one. The persistent irritant of implicit ignorance about obesity confronts us in virtually every dialogue we have about obesity. Sometimes it gets to be too much. Specifically, it is the presumption woven into almost every conversation about obesity, that obesity is all about bad […]
January 18, 2024 — E.B. White is long gone from this life and Block That Metaphor! is dormant at The New Yorker. But we need them back. The Washington Post has a new and twisted metaphor about obesity treatment, casting Ozempic as something like orthodontia. Kate Cohen writes: “I always thought I’d be thin if I were rich. “I’d […]
September 7, 2023 — The Wegovy brand of semaglutide has finally come to the UK this week – albeit in limited quantities. So in the Guardian, Zoe Williams wonders if this will mean the end to blathering about obesity: “Despite this being a breakthrough, it is going to pose an immense challenge to those, in medicine and beyond, who […]
August 6, 2023 — On Friday, the Kaiser Family Foundation (KFF) released remarkably detailed results from a survey of public awareness and beliefs about new obesity medicines. It offers much for us to think about. But at the very top line it puts some solid numbers on a basic fact about the public response to breakthrough medicines for obesity. […]
May 25, 2023 — Are we ready for a re-think of obesity and metabolic health? Ready to change the conversation about obesity medicines and bariatric surgery? Sergio Santoro, Scott Shikora, and Ricardo Cohen certainly think so. Writing in Obesity Surgery, they say it’s time to say goodbye to bariatric surgery and move on to the framework of metabolic surgery. […]
May 20, 2023 — ECO2023 closed today with a clear focus on future progress in obesity. Lee Kaplan offered a view of what that future might look like with a focus on access and delivery of chronic care for obesity. Kaplan told us the future of obesity care lies in getting beyond merely saying that obesity is a disease. […]
December 2, 2022 — It doesn’t take a genius to understand the futility of sprinting in a marathon. But it does seem to take some knowledge and insight to differentiate between the sprint of short-term weight loss and the marathon of obesity treatment. Right now that distinction matters because of a short supply of drugs that are medically necessary […]
November 20, 2022 — Fed up. That’s where we are with stories about how people taking semaglutide for obesity are keeping people with diabetes from getting an adequate supply of the drug they need. Fed up, because it’s a stealthy way of expressing implicit bias against people living with obesity. The subtext is that those people don’t really need […]
